Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis.
Saved in:
| Title: | Infection risk in inflammatory bowel disease patients treated with vedolizumab: a systematic review and meta-analysis. |
|---|---|
| Authors: | Zhang L; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China., Hao X; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China., Cui Y; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China., Yan W; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China., Shang K; College of Pharmacy, Changchun University of Chinese Medicine, Changchun, China., Zhang X; College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, China. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2026 Jun 11; Vol. 13, pp. 1806488. Date of Electronic Publication: 2026 Jun 11 (Print Publication: 2026). |
| Publication Type: | Journal Article; Systematic Review |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2296-858X |
|---|---|
| DOI: | 10.3389/fmed.2026.1806488 |
